Temozolomide Capsule
Product Images NDC 72162-2662

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 72162-2662). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622662)

This text provides information about Temozolomide capsules containing 140 mg for oral administration. It instructs to scan the package insert QR code for directions and dosage recommendations. The capsules are manufactured in Turkey and should be stored at controlled room temperature. It emphasizes keeping the drug out of children's reach and provides details on relabeling by Bryant Ranch Prepack, Inc. It also includes the NDC number and the manufacturer information.*

FDA Label Image

Kaplan-meier Curves (Temo Fig2)

The text provides statistical data on Overall Survival in an ITT (Intent-to-Treat) Population. The Hazard Ratio (HR) is 0.63 with a 95% Confidence Interval from 0.52 to 0.75. The log-rank P-value is less than 0.0001, indicating statistical significance. The time points provided (12, 16, 20, 24, and 28 months) likely represent intervals in the study regarding the Time from randomization.*

FDA Label Image

Chemical-structure (Temo Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.